Prosecution Insights
Last updated: October 01, 2026

Examiner: LE, AUSTIN Q

Tech Center 1700 • Art Units: 1651 1796 1798 1799

This examiner grants 50% of resolved cases

Analysis

Austin Q. Le has resolved 171 cases in Tech Center 1700, specifically in Art Unit 1651. The examiner's allowance rate of 49.7 percent indicates a balanced outcome between grants and abandonments, suggesting that applicants face a significant hurdle in securing a patent. This 49.7 percent rate implies that about half of the applications in this unit will require substantial effort to reach a grant.

The interview lift of 31.0 percent is notable, implying that interviews are an effective method for resolving issues and moving toward an allowance. The median days to allowance is 1354, which represents a long prosecution timeline that requires patience. Practitioners should use the 31.0 percent lift strategically to navigate this environment, as the data suggests that direct communication is one of the most effective ways to improve the odds of success. The 1354-day median pendency highlights the importance of a proactive and well-planned prosecution strategy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

49.7%
Allow Rate
-15.3% vs TC avg
218
Total Applications
+31.0%
Interview Lift
1354
Avg Prosecution Days
Based on 171 resolved cases, 2023–2026

Rejection Statute Breakdown

0.2%
§101 Eligibility
20.4%
§102 Novelty
51.3%
§103 Obviousness
26.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17980315 NANOSTRUCTURED SYSTEM FOR FLUOROMETRIC NUCLEIC ACID AMPLIFICATION Final Rejection Samsung Electronics Co., Ltd.
17332812 DEVICE AND METHOD FOR DETECTING PROTEIN-BASED MARKER, AND METHOD FOR MANUFACTURING CHIP Final Rejection BOE TECHNOLOGY GROUP CO., LTD.
18705941 Systems and Methods for Sample Analysis Non-Final OA Abbott Laboratories
18554777 L-Shaped Cartridge Non-Final OA Robert Bosch GmbH
18263819 Device and Method for Separating Blood Plasma from Whole Blood Final Rejection Robert Bosch GmbH
18358539 MICROFLUIDIC DEVICE AND CLASSIFICATION METHOD Non-Final OA Canon Kabushiki Kaisha
17185749 COMPOSITIONS, METHODS AND SYSTEMS FOR SAMPLE PROCESSING Non-Final OA 10X Genomics, Inc.
17274496 ARRANGEMENT FOR IMPLEMENTATION OF IN VITRO BIOCOMPATIBILITY TESTS Final Rejection Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.V.
17444397 SAMPLE CONTAINER TRANSPORT SYSTEM Non-Final OA Roche Diagnostics Operations, Inc.
18370275 ANALYSIS SYSTEM Final Rejection SHIMADZU CORPORATION
18237530 MICROCHANNEL DEVICE Final Rejection SHIMADZU CORPORATION
17348504 TISSUE SAMPLE STORAGE SYSTEM Final Rejection University of Washington
17947007 TARGET CAPTURE AND SENSOR ASSEMBLY FABRICATION METHOD AND TARGET CAPTURE AND SENSOR ASSEMBLY Final Rejection Analog Devices, Inc.
17893658 RIGID FRAME BAGS Final Rejection ENTEGRIS, INC.
17919389 CARBON DIOXIDE DETECTOR Final Rejection MITSUBISHI GAS CHEMICAL COMPANY, INC.
17426226 LIQUID HANDLING INSTRUMENT AND PIPETTING HEAD FOR AND METHOD OF ASPIRATING AND/OR DISPENSING LIQUIDS Non-Final OA Formulatrix, Inc.
18191164 PARAFFIN-EMBEDDED BLOCK PREPARATION DEVICE Non-Final OA JOKOH CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month